188 related articles for article (PubMed ID: 33323173)
1. Evaluation of epithelial and mesenchymal cell markers in canine urinary bladder transitional cell carcinoma.
Shinada M; Saeki K; Yoshitake R; Eto S; Tsuboi M; Chambers JK; Uchida K; Kato D; Yoshimoto S; Kamoto S; Ikeda N; Kinoshita R; Fujita N; Nishimura R; Nakagawa T
Vet J; 2020 Dec; 266():105571. PubMed ID: 33323173
[TBL] [Abstract][Full Text] [Related]
2. Expression of cell cycle regulators, 14-3-3σ and p53 proteins, and vimentin in canine transitional cell carcinoma of the urinary bladder.
Suárez-Bonnet A; Herráez P; Aguirre M; Suárez-Bonnet E; Andrada M; Rodríguez F; Espinosa de Los Monteros A
Urol Oncol; 2015 Jul; 33(7):332.e1-7. PubMed ID: 25979650
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the molecular and immune landscape of canine bladder cancer.
Cronise KE; Das S; Hernandez BG; Regan DP; Dailey DD; McGeachan RI; Lana SE; Page RL; Gustafson DL; Duval DL
Vet Comp Oncol; 2022 Mar; 20(1):69-81. PubMed ID: 34021685
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of p63, Ki67 and β-catenin in canine transitional cell carcinoma and polypoid cystitis of the urinary bladder.
Hanazono K; Nishimori T; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Uchide T
Vet Comp Oncol; 2016 Sep; 14(3):263-9. PubMed ID: 24758385
[TBL] [Abstract][Full Text] [Related]
6. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
[TBL] [Abstract][Full Text] [Related]
7. Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder.
Nomura S; Suzuki Y; Akatsuka J; Endo Y; Shimizu A; Hamasaki T; Kimura G; Kondo Y
BMC Urol; 2020 Jun; 20(1):72. PubMed ID: 32571273
[TBL] [Abstract][Full Text] [Related]
8. Expression of mesenchymal markers vimentin and fibronectin: the clinical significance in esophageal squamous cell carcinoma.
Sudo T; Iwaya T; Nishida N; Sawada G; Takahashi Y; Ishibashi M; Shibata K; Fujita H; Shirouzu K; Mori M; Mimori K
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S324-35. PubMed ID: 22644514
[TBL] [Abstract][Full Text] [Related]
9. Expression of HMGA2 in bladder cancer and its association with epithelial-to-mesenchymal transition.
Ding X; Wang Y; Ma X; Guo H; Yan X; Chi Q; Li J; Hou Y; Wang C
Cell Prolif; 2014 Apr; 47(2):146-51. PubMed ID: 24571540
[TBL] [Abstract][Full Text] [Related]
10. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
[TBL] [Abstract][Full Text] [Related]
11. Assessment of HER2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder.
Tsuboi M; Sakai K; Maeda S; Chambers JK; Yonezawa T; Matsuki N; Uchida K; Nakayama H
Vet Pathol; 2019 May; 56(3):369-376. PubMed ID: 30612533
[TBL] [Abstract][Full Text] [Related]
12. Pathology of canine bladder and urethral cancer and correlation with tumour progression and survival.
Valli VE; Norris A; Jacobs RM; Laing E; Withrow S; Macy D; Tomlinson J; McCaw D; Ogilvie GK; Pidgeon G
J Comp Pathol; 1995 Aug; 113(2):113-30. PubMed ID: 8543669
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of vimentin in canine prostatic carcinoma.
Rodrigues MM; Rema A; Gärtner F; Soares FA; Rogatto SR; De Mour VM; Laufer-Amorim R
J Comp Pathol; 2011 May; 144(4):308-11. PubMed ID: 20961558
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-to-mesenchymal transition: immunohistochemical investigation of related molecules in canine cutaneous epithelial tumours.
Bongiovanni L; D'Andrea A; Romanucci M; Malatesta D; Candolini M; Salda LD; Mechelli L; Sforna M; Brachelente C
Vet Dermatol; 2013 Feb; 24(1):195-203.e42-3. PubMed ID: 23331698
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of ΔNp63 expression in canine transitional cell carcinoma of the urinary bladder.
Nishimori T; Hanazono K; Matsuda K; Kawamura Y; Kadosawa T; Endo Y; Uchide T
Open Vet J; 2021; 11(4):700-706. PubMed ID: 35070867
[TBL] [Abstract][Full Text] [Related]
16. Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
Liu B; Miyake H; Nishikawa M; Fujisawa M
Urol Oncol; 2015 Mar; 33(3):110.e11-8. PubMed ID: 25262382
[TBL] [Abstract][Full Text] [Related]
17. [Transitional cell carcinoma of the urinary bladder of a dog].
Odendaal JS; Bastianello SS
J S Afr Vet Assoc; 1982 Dec; 53(4):258-60. PubMed ID: 7182501
[TBL] [Abstract][Full Text] [Related]
18. Lipoxygenase-5 Expression in Canine Urinary Bladder: Normal Urothelium, Cystitis and Transitional Cell Carcinoma.
Finotello R; Schiavo L; Ressel L; Frohmader A; Silvestrini P; Verin R
J Comp Pathol; 2019 Jul; 170():1-9. PubMed ID: 31375151
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
[TBL] [Abstract][Full Text] [Related]
20. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.
Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Uchida K; Kadosawa T; Taniyama H
Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
